Literature DB >> 9238052

Pig but not human interferon-gamma initiates human cell-mediated rejection of pig tissue in vivo.

P Sultan1, A G Murray, J M McNiff, M I Lorber, P W Askenase, A L Bothwell, J S Pober.   

Abstract

Split-thickness pig skin was transplanted on severe combined immunodeficient mice so that pig dermal microvessels spontaneously inosculated with mouse microvessels and functioned to perfuse the grafts. Pig endothelial cells in the healed grafts constitutively expressed class I and class II major histocompatibility complex molecules. Major histocompatibility complex molecule expression could be further increased by intradermal injection of pig interferon-gamma (IFN-gamma) but not human IFN-gamma or tumor necrosis factor. Grafts injected with pig IFN-gamma also developed a sparse infiltrate of mouse neutrophils and eosinophils without evidence of injury. Introduction of human peripheral blood mononuclear cells into the animals by intraperitoneal inoculation resulted in sparse perivascular mononuclear cell infiltrates in the grafts confined to the pig dermis. Injection of pig skin grafts on mice that received human peripheral blood mononuclear cells with pig IFN-gamma (but not human IFN-gamma or heat-inactivated pig IFN-gamma) induced human CD4(+) and CD8(+) T cells and macrophages to more extensively infiltrate the pig skin grafts and injure pig dermal microvessels. These findings suggest that human T cell-mediated rejection of xenotransplanted pig organs may be prevented if cellular sources of pig interferon (e.g., passenger lymphocytes) are eliminated from the graft.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9238052      PMCID: PMC23121          DOI: 10.1073/pnas.94.16.8767

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

1.  Porcine endothelial CD86 is a major costimulator of xenogeneic human T cells: cloning, sequencing, and functional expression in human endothelial cells.

Authors:  S E Maher; K Karmann; W Min; C C Hughes; J S Pober; A L Bothwell
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

Review 2.  Transplantation of discordant xenografts: a challenge revisited.

Authors:  W Parker; S Saadi; S S Lin; Z E Holzknecht; M Bustos; J L Platt
Journal:  Immunol Today       Date:  1996-08

Review 3.  Xenotransplantation.

Authors:  C L Kaufman; B A Gaines; S T Ildstad
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

Review 4.  Xenotransplantation: a view to the future.

Authors:  F H Bach
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

5.  Acute rejection of vascularized heart allografts in the absence of IFNgamma.

Authors:  S Saleem; B T Konieczny; R P Lowry; F K Baddoura; F G Lakkis
Journal:  Transplantation       Date:  1996-12-27       Impact factor: 4.939

6.  Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse.

Authors:  A G Murray; P Petzelbauer; C C Hughes; J Costa; P Askenase; J S Pober
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

7.  Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2.

Authors:  S A Rollins; S P Kennedy; A J Chodera; E A Elliott; G B Zavoico; L A Matis
Journal:  Transplantation       Date:  1994-06-27       Impact factor: 4.939

8.  Direct recognition of SLA- and HLA-like class II antigens on porcine endothelium by human T cells results in T cell activation and release of interleukin-2.

Authors:  C A Bravery; P Batten; M H Yacoub; M L Rose
Journal:  Transplantation       Date:  1995-11-15       Impact factor: 4.939

9.  Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon.

Authors:  J S Pober; M A Gimbrone; R S Cotran; C S Reiss; S J Burakoff; W Fiers; K A Ault
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

10.  Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response.

Authors:  H F Dvorak; M C Mihm; A M Dvorak; B A Barnes; E J Manseau; S J Galli
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Immunobiology of human vascular endothelium.

Authors:  J S Pober
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Islet xenograft destruction in the hu-PBL-severe combined immunodeficient (SCID) mouse necessitates anti-CD3 preactivation of human immune cells.

Authors:  C Gysemans; M Waer; J Laureys; J Depovere; D Pipeleers; R Bouillon; C Mathieu
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

Review 3.  Progress in xenotransplantation: overcoming immune barriers.

Authors:  Megan Sykes; David H Sachs
Journal:  Nat Rev Nephrol       Date:  2022-10-05       Impact factor: 42.439

Review 4.  Xenotransplantation: immunological hurdles and progress toward tolerance.

Authors:  Adam Griesemer; Kazuhiko Yamada; Megan Sykes
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

5.  Development of a humanized mouse model to study the role of macrophages in allograft injury.

Authors:  Nancy C Kirkiles-Smith; Martha J Harding; Benjamin R Shepherd; Stacey A Fader; Tai Yi; Yinong Wang; Jennifer M McNiff; Edward L Snyder; Marc I Lorber; George Tellides; Jordan S Pober
Journal:  Transplantation       Date:  2009-01-27       Impact factor: 4.939

Review 6.  Transplanting organs from pigs to humans.

Authors:  Megan Sykes; David H Sachs
Journal:  Sci Immunol       Date:  2019-11-01

Review 7.  Mouse models with human immunity and their application in biomedical research.

Authors:  Baojun Zhang; Ziyuan Duan; Yong Zhao
Journal:  J Cell Mol Med       Date:  2008-04-15       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.